Germany: Laboratory Software Merck Acquires Lab Informatics Company
Merck has acquired BSSN Software, a Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving. Financial details were not disclosed.
Related Vendors

Darmstadt/Germany — With the acquisition of BSSN Software, Merck intends to allow its customers to better use and share their scientific data. Jean-Charles Wirth, head of Applied Solutions at the Life Science business sector of Merck explained that the company was acquired for commercial growth of the lab data management technology that BSSN provided for many years. The acquisition is to complement the company's efforts to support its customers’ digital transformation in the lab. BSSN’s employees have joined Merck as part of its Applied Digital Lab Productivity Solutions team.
BSSN Software is known for developing and marketing data management and integration software that unifies data from instruments and data systems and makes them available for analyzing, processing and sharing. It collects and converts scientific data from a broad range of more than 200 lab instrument models into a single, unified format. As a middleware offering, it facilitates communication and data flow between instruments and systems, such as laboratory information management systems, electronic lab notebooks and enterprise resource planning systems.
:quality(80)/images.vogel.de/vogelonline/bdb/1358300/1358361/original.jpg)
Germany: Biopharmaceutical Manufacturing
Merck Plans Additional Investment in Manufacturing and Distribution Platform in Asia
Since 2014, the life sciences company has been working with BSSN Software, which primarily served pharmaceutical and food and beverage customers and provided services to facilitate standard laboratory efforts. BSSN Software was the first company to introduce to the market a complete AnIML implementation, an open standardized XML data format for storing and sharing of experiment data. With this acquisition, Merck is combining BSSN’s technology with its market access and laboratory domain knowledge to develop and commercialize an open and interoperable platform for laboratory data.
(ID:46081608)